RP-6306 |
RP-6306 : Inhibitor of PKMYT1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| PKMYT1 |
|
|
Inhibitor
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
RP-6306 was tested in a Kinativ Colo-205 cell lysate kinase binding assay at 1.2 μM binding to only ...
Potency Cellular
In Vitro
PKMYT1
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.2c00552
In Vivo Validations
Rat
Dose: 1 mg/Kg IV, 2.5 or 5 mg/Kg PO
Route of delivery:
Intravenous, Oral
Systemic clearance:
198 mL/min/kg
Fb :
87.7%
Bioavailability:
48%
Target engagement assay:
Potent in vivo PKMYT1 target inhibition and direct relationship between RP-6306 free plasma levels and tumor pCDK1(Thr14) inhibition: EC50 to inhibit pCDK1(Thr14) by 50% was calculated as 0.20 nM and EC90 as 11 nM.
DOI Reference: 10.1021/acs.jmedchem.2c00552
Negative Control Compounds
Cpd 4
Notes: In cell IC50 > 3 uM
SMILES:
NC(C1=C(N)N(C2=CC=CC(O)=C2C)C3=NC4=C(C=CC=C4)N=C31)=O
Chemical Information
| Molecular Formula | C18H20N4O2 |
| SMILEs | Cc1cc2c(C(N)=O)c(N)n(-c3c(C)ccc(O)c3C)c2nc1C |
| InChI | InChI=1S/C18H20N4O2/c1-8-5-6-13(23)10(3)15(8)22-16(19)14(17(20)24)12-7-9(2)11(4)21-18(12)22/h5-7,23H,19H2,1-4H3,(H2,20,24) |
| Molecular weight | 324.16 Da |
| AlogP | 0.0 |
| HBond acceptors | 6 |
| HBond donors | 5 |
| Atoms | 44 |
| PAINS * | Yes |
* This is an automated alert only, and may not necessarily indicate an issue with this probe. ( Learn more about PAINS )
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.